Institut Pasteur

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Dragonfly Takes Back IL-12 Immunotherap

Cash is flooding into biopharmaceuticals, but regenerative medicine companies in particular have raked in large sums of cash – in part, because of the high upfront investment in manufacturing, but als

Indian firm Zydus Cadila is to commence Phase III trials of its recombinant DNA vaccine candidate ZyCoV-D as a three-dose COVID-19 vaccine, the protocol registered prospectively on India’s online cl

Merck & Co., Inc. chairman and chief executive officer Kenneth Frazier took on a host of burning questions, including around the pricing of potential COVID-19 therapeutics and vaccines, and on the re